Comments
Aspira Pathlab and Diagnostics Ltd.’s shares were up by 20 per cent after the company reported a 151 per cent increase in profit for Q1 at ₹71.60 lakh.
The company’s revenues were down by 12 per cent to ₹2.60 crore. Sequentially, the company’s profits were higher by 176 per cent compared to ₹25.93 lakh in the previous quarter.
The company also announced that the board had discussed contemplation of increasing promoter stake in the company via an Open Offer and exploration of enhanced business collaborations with the Promoter Company, Yashraj Biotechnology Limited.
These discussions were preliminary in nature and will only be finalised upon formal decisions and agreements.
The shares were up by 20 per cent to ₹32 at 09.39 on BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.